In lung cancer, the anti-cancer gene miR-320b downregulates the expression of IGF2BP2 and thymidine kinase 1 (TK1), thus suppressing angiogenesis and lung cancer growth [74] (Fig. 2). The gene discussed is TK1; the disease is lung carcinoma.